Tirzepatide represents a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://delilahzlts302418.blog-ezine.com/41070208/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist